Similar Search Results

Competition and physician behaviour : does the competitive environment affect the propensity to issue sickness certificates?

Brekke, Kurt R.; Holmås, Tor Helge; Monstad, Karin; … - 2017

Competition among physicians is widespread, but compelling empirical evidence on the impact on service provision is … (emergency centre). Using rich administrative patient- level data from Norway for 2006-14, which allow us to estimate high …

Persistent link: https://www.econbiz.de/10011734380

Prescription behavior of physicians in the public and private sector

Jussila, Elina; Kotakorpi, Kaisa; Verho, Jouko - 2022

We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …

Persistent link: https://www.econbiz.de/10013482204

Sick leave cuts and (unhealthy) returns to work

Marie, Olivier; Vall Castello, Judit - 2022

We investigate the impact on work absence of a massive reduction in paid sick leave benefits. We exploit a policy change that only affected public sector workers in Spain and compare changes in the number and length of spells they take relative to unaffected private sector workers. Our results...

Persistent link: https://www.econbiz.de/10012806663

Strategic interaction in the market for physician services : the treadmill effect in a fixed budget system

Benstetter, Franz; Wambach, Achim - 2001

We examine the strategic interaction in the market for physician services when the total budget for reimbursement is fixed. We show that this prospective payment system involves { compared to a fee-for-service remuneration system { a severe coordination problem, which potentially leads to the...

Persistent link: https://www.econbiz.de/10011398025

A probability approach to pharmaceutical demand and price setting : does the identity of the third-party payer matters for prescribing doctors?

Dalen, Dag Morten; Locatelli Biey, Marilena; Sorisio, Enrico - 2011

accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique … natural policy experiment in Norway, to what extent the price responsiveness of prescription choices is affected when the …

Persistent link: https://www.econbiz.de/10009377790

Health service gatekeepers

Malcomson, James - 2003

Incentive contracts for gatekeepers who control patient access to specialist medical services provide too weak incentives to investigate cost further when expected cost of treatment is greater than benefit. Making gatekeepers residual claimants with a fixed fee from which treat-ment costs must...

Persistent link: https://www.econbiz.de/10011511048

Demand patterns for treatment insurance in Norway

Aarbu, Karl Ove - 2010

this phenomenon, using data from Norway. First, using available market data, I document that the market for private …

Persistent link: https://www.econbiz.de/10003965860

Price regulation and parallel imports of pharmaceuticals

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2015

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...

Persistent link: https://www.econbiz.de/10011305382

Margins and market shares : pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...

Persistent link: https://www.econbiz.de/10009691207

Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …

Persistent link: https://www.econbiz.de/10008749029

1
2
3
4
5
6
7
8
9
10
Next
Last